Friday, May 9, 2025

thumbnail

How Does Artemisinin Kill Malaria Parasites? A Simple Explanation for Newcomers

 

Understanding Artemisinin: How This Ancient Remedy Fights Malaria Fast


Artemisinin, a compound extracted from the Artemisia annua plant (commonly known as sweet wormwood), has revolutionized modern malaria treatment. Used in combination therapies across the world, this potent drug belongs to a special class of natural compounds known as sesquiterpene lactones—which are characterized by a 15-carbon backbone and a reactive lactone ring.

How Does Artemisinin Work?

Artemisinin is activated inside malaria-infected red blood cells by iron or heme, which are byproducts of the parasite digesting hemoglobin. This activation breaks the compound’s endoperoxide bridge, releasing reactive free radicals. The endoperoxide bridge is essentially a pair of oxygen atoms linked together.

These radicals then:

  • Damage parasite proteins and membranes

  • Disrupt redox and proteostasis systems 

  • Alkylate specific targets like PfPI3K

The result is swift and effective destruction of the Plasmodium parasite, particularly at the early ring stage.

Why Modify Artemisinin?

As noted by Heller and Roepe (2019), the natural form of artemisinin has low water solubility and a very short half-life in the human body. To address these limitations, several semi-synthetic derivatives have been developed:

Derivative

Key Benefit

Artesunate

Water-soluble; can be given IV

Artemether

Lipid-soluble; longer bioactivity

Dihydroartemisinin (DHA)

Active metabolite of both artesunate and artemether; highly potent

These modifications improve:

  • Solubility (for injectable or oral use)

  • Bioavailability

  • Pharmacokinetic properties (slightly extended half-life)

  • Clinical flexibility (used in both severe and uncomplicated malaria)

The result is a family of artemisinin-based drugs suited for different routes of administration and treatment settings.

Half-life: Why Combination Matters

Despite these improvements, artemisinin derivatives still clear the body within 1 to 3 hours, making them unsuitable for monotherapy. That’s why they are combined with longer-acting partner drugs like lumefantrine or piperaquine in Artemisinin-based Combination Therapies (ACTs)—which reduce treatment failure and delay resistance.

Quick Science Note: 10⁻⁸ M = 10 nM

When testing artemisinin in the lab, a concentration of 10⁻⁸ M equals 10 nanomolar (nM)—a common range for assessing antimalarial potency in vitro.

Conclusion

  • Artemisinin is a sesquiterpene lactone with a reactive endoperoxide bridge.

  • It kills malaria parasites rapidly by producing toxic radicals inside infected cells.

  • Derivatives like artesunate and artemether improve its solubility, potency, and pharmacokinetics.

  • Due to its short half-life, artemisinin is always used in combination therapy to ensure full clearance of the parasite and prevent resistance.


Reference

📚 Citation: Heller, L. E., & Roepe, P. D. (2019). Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance. Tropical Medicine and Infectious Disease, 4(2), 89. https://doi.org/10.3390/TROPICALMED4020089


Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

About

Search This Blog

Powered by Blogger.

About Me

My photo
Adwoa Agyapomaa has a BSc from RMIT, Australia and an MPH from Monash University, Australia. Adwoa is the founder of Adwoa Biotech. She is currently a Senior Research Assistant. Enjoyed the tutorial? Connect with me on YouTube [Adwoa Biotech] where we talk biotech techniques, and lab workflows.